Furthermore, CLDN18high ICC tumors exhibited downregulated CD8+ TILs activation markers (TNFRSF4, GZMB) and upregulated immune checkpoints (PD-L1, CTLA-4) (Figures 3D, E, all P < 0.05). The gene discussed is CD8A; the disease is intrahepatic cholangiocarcinoma.